Search results
Author(s):
Joo-Yong Hahn
Added:
1 month ago
ACC 25 - SMART-CHOICE 3 Trial finds clopidogrel monotherapy to be the optimal anti-thrombotic strategy in high risk patients with contemporary drug-eluting stents.Dr Joo-Yong Hahn (Samsung Medical Center, Seoul, KR) joins us onsite at ACC Conference 2025 to discuss the findings from the SMART-CHOICE 3 study (NCT04418479). The study aims to evaluate the efficacy and safety of clopidogrel…
View more
Author(s):
Cheng Keat Tan
,
David Bin-Chia Wu
,
Seh Yi Joseph Tan
,
et al
Added:
1 year ago
Keith AA Fox
Research Area(s) / Expertise:
Job title: Professor
Author
Author(s):
Masahiro Natsuaki
Added:
1 year ago
ESC 23 — Dr Masahiro Natsuaki (Saga University, JP) discusses the short and optimal duration of dual antiplatelet therapy-3 Study (STOPDAPT-3) (NCT04609111).
In the STOPDAPT-2 study, 1-month dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy was shown to provide benefits in bleeding reduction over a 12-month period, however, other trials have shown high rates of bleeding at…
View more
Author(s):
Manav Sohal
Added:
9 months ago
Author(s):
Giuseppe Ferrante
,
Brittany A Bacallao
,
Francesco Gioia
,
et al
Added:
5 months ago
Author(s):
Filippo Gurgoglione
,
Giampaolo Niccoli
Added:
5 months ago
Author(s):
Tobias Geisler
Added:
10 months ago
Author(s):
Andrea Di Lenarda
,
Nicola Ferri
,
Massimiliano Lanzafame
,
et al
Added:
9 months ago
Author(s):
Pierluigi Merella
,
Giuseppe Talanas
,
Giovanni Lorenzoni
,
et al
Added:
1 year ago